Evidence map›Paper›PMID 35321551›Full record

ArticleJournal of clinical microbiology2022

Performance of COVIDSeq and Swift Normalase Amplicon SARS-CoV-2 Panels for SARS-CoV-2 Genome Sequencing: Practical Guide and Combining FASTQ Strategy.

Hosoon Choi, Munok Hwang, Dhammika H Navarathna, Jing Xu, Janell Lukey, Chetan Jinadatha

Abstract readLetter
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Nationwide Genomic Surveillance and Response to COVID-19: The VA SeqFORCE and SeqCURE Consortiums.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2023
    Article
  7. A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hosoon ChoiDepartment of Research, Central Texas Veterans Health Care Systemgrid.413775.3, Temple, Texas, USA.
Munok HwangDepartment of Research, Central Texas Veterans Health Care Systemgrid.413775.3, Temple, Texas, USA.
Dhammika H NavarathnaDepartment of Pathology and Laboratory Medicine Services, Central Texas Veterans Health Care Systemgrid.413775.3, Temple, Texas, USA.ORCID 0000-0003-0070-5919
Jing XuDepartment of Research, Central Texas Veterans Health Care Systemgrid.413775.3, Temple, Texas, USA.
Janell LukeyDepartment of Pathology and Laboratory Medicine Services, Central Texas Veterans Health Care Systemgrid.413775.3, Temple, Texas, USA.
Chetan JinadathaDepartment of Medicine, Central Texas Veterans Health Care Systemgrid.413775.3, Temple, Texas, USA.ORCID 0000-0002-3916-952X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Base SequenceGenome, ViralHumansRNA, ViralRNA, ViralcladeCOVIDCOVIDSeqCT valuelineageSARS-CoV-2sequencingswift

Identifiers

PMID35321551
PMCPMC9067563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.